Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 3.

Journal Article

Horgan, Denis, Curigliano, Giuseppe ORCID: 0000-0003-1781-2518, Riess, Olaf, Hofman, Paul ORCID: 0000-0003-0431-9353, Buettner, Reinhard, Conte, Pierfranco, Cufer, Tanja, Gallagher, William M., Georges, Nadia, Kerr, Keith, Penault-Llorca, Frederique, Mastris, Ken ORCID: 0000-0002-6074-8147, Pinto, Carla, Van Meerbeeck, Jan, Munzone, Elisabetta, Thomas, Marlene, Ujupan, Sonia, Vainer, Gilad W. ORCID: 0000-0002-8828-8138, Velthaus, Janna-Lisa and Andre, Fabrice (2022). Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. J. Pers. Med., 12 (1). BASEL: MDPI. ISSN 2075-4426

Miller, Kathy D., Dieras, Veronique, Harbeck, Nadia, Andre, Fabrice, Mahtani, Reshma L., Gianni, Luca, Albain, Kathy S., Crivellari, Diana, Fang, Liang, Michelson, Glenn, de Haas, Sanne L. and Burris, Howard A. (2014). Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer. J. Clin. Oncol., 32 (14). S. 1437 - 1446. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Nogova, Lucia, Sequist, Lecia V., Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H. M., Cassier, Philippe A., Camidge, D. Ross, Schuler, Martin, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Burris, Howard, Tian, G. Gary, Campone, Mario, Wainberg, Zev A., Lim, Wan-Teck ORCID: 0000-0002-4655-0206, LoRusso, Patricia, Shapiro, Geoffrey I., Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard and Wolf, Juergen (2017). Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study. J. Clin. Oncol., 35 (2). S. 157 - 176. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Wed Apr 17 16:18:09 2024 CEST.